💡 The Challenge. The Evidence. The Solution. Ventilator-Associated Pneumonia (VAP) remains a serious clinical issue in UK ICUs with NHS England data estimating 3,000–6,000 deaths per year and treatment costs of £10,000–£20,000 US$ 21.20 Min. order: 1 piece ★★★★★ 4.0 (214 reviews) Sold : Login>>
❇️Best Of SCC❇️ An early BAL protocol identified trauma patients w/ early pneumonia, a separate entity from ventilator-associated pneumonia. Patients were treated based on clinical signs. There was no difference in clinical US$ 27.57 Min. order: 1 piece ★★★★★ 4.3 (269 reviews) Sold : Login>>
The PROPHY-VAP Trial: Ceftriaxone to Prevent VAP in Patients with Acute Brain Injury - REBEL EM US$ 24.70 Min. order: 1 piece ★★★★★ 4.9 (259 reviews) Sold : Login>>
Strategies in the prevention of ventilator-associated pneumonia US$ 26.12 Min. order: 1 piece ★★★★★ 5.0 (261 reviews) Sold : Login>>
Figure 3 from Ventilator-associated pneumonia: a review US$ 24.69 Min. order: 1 piece ★★★★★ 4.4 (214 reviews) Sold : Login>>